Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice-Reference-Cited by-同舟云学术

Efficacy and Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Korean Patients with Type 2 Diabetes Mellitus in Real-World Clinical Practice

Published:2019 Issue:5 Volume:43 Page:590
ISSN:2233-6079
Container-title:Diabetes & Metabolism Journal
language:en
Short-container-title:Diabetes Metab J

Author:

Hong A Ram¹^ORCID,Koo Bo Kyung²³,Kim Sang Wan²³,Yi Ka Hee²³,Moon Min Kyong²³^ORCID

Affiliation:

1. Department of Internal Medicine, Chonnam National University Medical School, Gwangju, Korea.

2. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

3. Department of Internal Medicine, Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul, Korea.

Publisher

Korean Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism

Link

https://synapse.koreamed.org/pdf/10.4093/dmj.2018.0134

Reference47 articles.

1. Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

2. Korean Diabetes Association. Diabetes fact sheet in Korea 2018. cited 2019 Jan 12. http://www.diabetes.or.kr/bbs/skin/dianews/download.php?code=admin&number=1694

3. Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes

4. 8. Pharmacologic Approaches to Glycemic Treatment

5. Lowering plasma glucose concentration by inhibiting renal sodium-glucose cotransport

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of SGLT-2 Inhibitors on Cardiac Function, Blood Glucose Levels, and Prognosis in Patients with Type 2 Diabetes Mellitus after Percutaneous Coronary Intervention: A Propensity Score Matching Study;The Heart Surgery Forum;2024-07-15

2. Effectiveness and Safety of Sodium-Glucose Cotransporter 2 Inhibitors Added to Dual or Triple Treatment in Patients with Type 2 Diabetes Mellitus;Diabetes Therapy;2023-12-20

3. Efficacy and Safety of Evogliptin Add-on Therapy to Dapagliflozin/Metformin Combinations in Patients with Poorly Controlled Type 2 Diabetes Mellitus: A 24-Week Multicenter Randomized Placebo-Controlled Parallel-Design Phase-3 Trial with a 28-Week Extension;Diabetes & Metabolism Journal;2023-11-30

4. Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study;Diabetes, Obesity and Metabolism;2023-06-20

5. To assess the level of serum uric acid in first trimester to predict gestational diabetes mellitus;CARDIOMETRY;2023-02-14